Early treatment with activated protein C for meningococcal septic shock: case report and literature review

被引：4
作者：
Hasin, T
Leibowitz, D
Rot, D
Weiss, Y
Chajek-Shaul, T
Nir-Paz, R [1 ]
机构：
[1] Hadassah Hebrew Univ Med Ctr, Dept Med, Jerusalem, Israel
[2] Hadassah Hebrew Univ Med Ctr, Dept Cardiol, Jerusalem, Israel
[3] Hadassah Hebrew Univ Med Ctr, Dept Anesthesiol & Intens Care, Jerusalem, Israel
[4] Hadassah Hebrew Univ Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel
[5] Univ Calif Berkeley, Dept Mol & Cell Biol, Portnoy Lab, Berkeley, CA 94720 USA
来源：
INTENSIVE CARE MEDICINE | 2005年 / 31卷 / 07期
关键词：
D O I：
10.1007/s00134-005-2653-x
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1002 / 1003
页数：2
相关论文
共 14 条
[1]   Protein C replacement in severe meningococcemia:: Rationale and clinical experience [J].
Alberio, L ;
Lämmle, B ;
Esmon, CT .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1338-1346
[2]   Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans [J].
Bachli, EB ;
Vavricka, SR ;
Walter, RB ;
Leschinger, MI ;
Maggiorini, M .
INTENSIVE CARE MEDICINE, 2003, 29 (02) :337-337
[3]  
Barton P, 2004, PEDIATRICS, V113, P7, DOI 10.1542/peds.113.1.7
[4]   Meningococcal septicaemia: treatment with protein C concentrate [J].
Clarke, RCN ;
Johnston, JR ;
Mayne, EE .
INTENSIVE CARE MEDICINE, 2000, 26 (04) :471-473
[5]   Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans [J].
Ettingshausen, CE ;
Veldmann, A ;
Beeg, T ;
Schneider, W ;
Jäger, G ;
Kreuz, W .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (06) :537-541
[6]   Dysfunction of endothelial protein C activation in severe meningococcal sepsis. [J].
Faust, SN ;
Levin, M ;
Harrison, OB ;
Goldin, RD ;
Lockhart, MS ;
Kondaveeti, S ;
Laszik, Z ;
Esmon, CT ;
Heyderman, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :408-416
[7]   Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study [J].
Fourrier, F ;
Leclerc, F ;
Aidan, K ;
Sadik, A ;
Jourdain, M ;
Tournoys, A ;
Noizet, O .
INTENSIVE CARE MEDICINE, 2003, 29 (07) :1081-1087
[8]   Protein C concentrate and recombinant tissue plasminogen activator in meningococcal septic shock [J].
Leclerc, F ;
Cremer, R ;
Leteurtre, S ;
Martinot, A ;
Fourier, C .
CRITICAL CARE MEDICINE, 2000, 28 (05) :1694-1696
[9]   Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome [J].
Rintala, E ;
Peuravuori, H ;
Pulkki, K ;
Voipio-Pulkki, LM ;
Nevalainen, T .
INTENSIVE CARE MEDICINE, 2000, 26 (09) :1248-1251
[10]   Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods [J].
Riordan, FAI ;
Marzouk, O ;
Thomson, APJ ;
Sills, JA ;
Hart, CA .
EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (10) :531-537
12